Dr. Humera Mahmood Dr. Humera Mahmood Radiation and Clinical Oncology

Dr. Humera Mahmood

Chief Oncologist

Director AECH NORI MBBS,FCPS,FRCP(UK)


Education

Following is the list of Degrees.

2018

FRCP | FRCP

Royal College of Physicians and Surgeons Glasgow, May 2018

1998

FCPS in Clinical Oncology | FCPS

College of Physicians and Surgeons of Pakistan (CPSP), Karachi in September 1998

1993

MBBS | MBBS

University of Punjab, Lahore, in First Division (1993)


Publications

Following is the list of Publications...

2024

Raheel Iftikhar, FCPS , Usman Ahmad, FRCPath, Ghulam Haider, FCPS, Humera Mahmood, FCPS, Maryam Khan, FCPS, Misbah Masood, FCPS, Nida Anwar, FCPS, Qamar Javed, FCPS, Nadia Sajid, FCPS, Rija Tariq, FCPS, Sana Mehmod, FCPS, Javeria Haider, FCPS, NargisAalam Abro, FCPS, Shanzah Shahbaz, FCPS, Abbas Khokhar, FCPS, ZeeshanAhmed Khan, FCPS, Hassan Pervez, MD, Munira Moosajee, MD https://orcid.org/0000-0002-2453-8919, and Zeba Aziz, MDReal-World Challenges of Managing Diffuse Large B-Cell Lymphoma in a Developing Country JCO Global Oncology Volume 10https://doi.org/10.1200/GO.23.00386 IF 4.5Published on April 11 2024.

2023

Supriya Chopra , Ankita Gupta, Hidefumi Aoyama ; Hong-Gyun Wu. Humera Mahmood,; EkkasitTharavichitkul ; Aung Khine Radiation Oncology Research in Asia: Current Status and a Peep Into the Future From the Federation of Asian Organizations for Radiation OncologyDOI: 10.1200/GO.23.00002 JCO Global Oncology no. 9 (2023) e2300002. Published online June 29, 2023. IF 4.5

2021

Hafsa Aziz, Shazia Fatima, Humera Mahmood, Shah Khalid Muhammad, Mohammad Adnan Saeed, Shaista Khurshid, Warda Haslam, Saeeda Aziz, and Mohammad Faheem. Antibody Response to SARS-CoV-2 in Relation to the Contributing Factors in COVID-19 Patients Viral Immunology

2020

Got published an article titled “Why to take the chance when you can do something about it—Cancer preventable, treatable and curable disease” in Daily Pakistan Observer on 4th Feb 2020 on the occasion of World Cancer Day”

2019

Mahmood Sana, Mahmood Humera, Mohammad Faheem Ewing Sarcoma of Tibia in Geriatric patient Excellent disease control without systemic therapyEJMO 2019:3(4):300-303 DOI: 10.14744/ejmo.2019.54956 IF:0.34

2018

Long-term impact on contouring skills can be achieved by online learning. An ESTRO-FALCON-IAEA study. Presented as Poster in ESTRO 37 Barcelona Spain and published in Green Journal Radiotherapy and Oncology Journal of European Society of Therapeutic Radiation Oncology Vol 127 Supplement 1 April 2018IF 6.901

2017

Humera Mahmood, Hadia Fatima and Mohammad Faheem Mammary Analogue Secretory Carcinoma of Parotid Gland in a Teenage Boy. JCPSP. 2017; Vol. 27 (9): 579-581. IF 1.022 36. IqraTanveer, S.U Rehman, Ghulam Asghar, Muhammad Muneer, Humera Mahmood, Mohammad Faheem Effective Doses Associated with CT Examinations and Radiation Induced Lifetime Cancer Risk Estimation PJR December 2017: 27(4): 353-57.

2016

Humera Mahmood, Mohammad Faheem, Sana Mahmood Association of Menopausal Status with Pathological Features of Tumor in Stage I to III A Breast Cancer Patients Treated With Upfront Modified Radical Mastectomy J Cancer PrevCurr Res 2016, 4(1): 000109. IF: 1.3

2015

Humera Mahmood, Mohammad Faheem, Sana Mahmood,Maryam Sadiq, Javaid IrfanImpact Of Age, Tumor Size, Lymph Node Metastases, Receptor Status, Her 2 Neu Positivity, Skin Involvement, Chest Wall Involvement And Menopausal Status On Overall Survival Of Breast Cancer Patients Asian Pac J Cancer Prev, 2015 16(3): 1019-24. IF 2.06

2014

Humera Mahmood, Mohammad Faheem, Tayyaba Saleem, Javaid Irfan Transitional Cell Carcinoma of Urinary Bladder in a Breast Cancer Survivor JCPSP 2014, Vol. 24 (Special Supplement 1): S60-S62. IF 1.022

2013

Humera Mahmood, Mohammad Faheem, Sana Mahmood and JavaidIrfan “Adenocarcinoma of Rectum as Second Primary Cancer after Treatment of Endometrial Cancer” JCPSP 2013, vol 23 (6): 434-436. IF 1.022

2012

Mohammad Faheem, Humera Mahmood, Mohammad Khurram, Uzma Qasim and JavaidIrfan “Estrogen receptor, progestrone receptor, and Her 2 Neu positivity and its association with tumor characteristics and menopausal status in a breast cancer cohort from northern Pakistan”. ecancer 2012, 6:283 DOL: 10.3332/ecancer.2012.283.IF2.078

2011

SA Adewuyi, N D Chom, S M Shehu, Humera Mahmood Preliminary Results on the Use of Bone Scanand Plain X-rays in the Evaluation of Bone Metastases from Breast Cancer in a Tertiary Institution: A study of 30 patients Nigerian Journal of Surgical Research July 2011. IF 0.27

2010

M. Masood, S.Ahmed, S.Kanwal, H.Mahmood, K.Ahmad, A.Mahmood, M.Faheem, N.Akbar Young age at first live birth and long duration of breast feeding: Are they universally accepted protective factors against breast cancer? A case control study of Cancer Research Group of Pakistan. Presented in 46th conference of American Society of Clinical Oncology (ASCO) and published in vol 28 no.15S Supplement to JCO May 20 2010. IF 50.739

2009

Asghar Hussain Asghar, Humera Mahmood, Mohammad Faheem, Sadia Rizvi, Abida Sajid,Javaid Irfan “Therapeutic effects of 20 Gray radiotherapy over a week in the management of brain metastases” published in JPMA. 59:278; 2009. IF 1.002

2007

Mohammad Faheem, Mohammad Khurram, Imran Ali Jafri, Humera Mahmood, Zubair Hassan, Ghulam Sabir Iqbal et al Risk factors for breast cancer in patients treated at NORI Hospital, Islamabad JPMA, Vol: 57(5), May 2007, p 242-45.IF 1.002 Citations 48

2006

Shaharyar, Abrar Ahmad Javed, Ijaz Hussein Shah, Tariq Nadeem Ansari, ShahidRasool,Muhammad Faheem, Humera Mahmood, Mazhar Ali Shah, Mohammad Saleem Khan, Mohammad Ali Afridi A Phase II study of Gemcitabine concurrent with radiation in locally advanced squamous cell carcinoma of head and neck: A trial of the Cancer Research Group of Pakistan; Pak J Med Sci Sep 2006;22(3):258-64. IF 2.36

2005

Naim Ahmad, Humera Mahmood “Quality assurance of Varisource high dose rate brachytherapy remote afterloader and cost effectiveness of Varisource HDR brachytherapy; NORI, Islamabad experience” published in October, 2005 in “The Nucleus” Vol. 41, Nos. 1-4 (2004), p:35-40. IF 3.49

2004

Humera Mahmood, Syed Amir Maqbool, Mohammad Faheem “Preliminary results of the role of combined modality treatment in muscle invasive Transitional cell carcinoma of urinary bladder” in JRMC vol: 8(1), Jan. to June 2004; p3-9..IF0.1